7 Small Biotech ETFs

Wave Life Sciences Ltd. Biohaven Pharmaceutical Holding Company Ltd. BCRX Infectious and inflammatory diseases. Publicly Traded Companies by Sector and Industry. Biopharmaceutical company; stereopure nucleic acid therapeutic candidates.

ETF Overview

ETFs allow market participants to invest in a group of companies, usually in a similar sector. The life science space can be risky, and ETFs are a good way to invest more safely. A key advantage is that if one company in the group takes a hit, the impact will be less direct for investors. All were selected using ETFdb. Of its holdings, the majority are small caps in the clinical-stage biotech sector, with a handful large-cap immunotherapy industry leaders on the top.

As its name implies, this ETF is a healthcare-first ETF, giving investors wide exposure to growth and value shares of small- to large-cap companies in the healthcare industry. There are 90 holdings included in this small biotech ETF.

Its four top holdings are large-cap companies weighted over 7 percent: With holdings , the top companies in this ETF include: Gilead Sciences, Amgen, Celgene and Biogen. This ETF is the only inverse biotech fund, making it a tactile tool. Which small biotech ETF do you think is the most auspicious? Tell us in the comments. This is an updated version of an article originally published by the Investing News Network in Wave Life Sciences Ltd.

Biopharmaceutical company; stereopure nucleic acid therapeutic candidates. PDLI Patents and royalty assets: ONVO 3D bioprinting technology. CHRS Biosimilar pure play. GBT Therapeutics for patients with grievous blood-based disorders. Cancer immunotherapy; pancreatic cancer.

ADXS Clinical-stage biotechnology company: ATRA Molecularly-targeted product candidates and T-cell product candidates; cancer, kidney disease and other illnesses.

Biopharmaceutical company with therapeutics designed to treat cancer. Gene-editing company; cancer therapies based on engineered T cells. CLDX Therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines; brain cancer, triple negative breast cancer. Biopharmaceutical company focused on immuno-oncology therapies for cancer. CRIS Drug candidates for the treatment of human cancers.

Biopharmaceutical company; antibody therapeutics, oncology. HALO Oncology therapies that target the tumor microenvironment. MNTA Therapeutics for oncology and autoimmune indications. RIGL Small-molecule drugs for the treatment of immune diseases and cancers. B-cell malignancies and autoimmune diseases. AXON Therapeutics designed to treat dementia. Biopharmaceutical company, gene control medicines.

In vivo gene therapy products designed to treat various diseases. ANIP Branded and generic prescription pharmaceuticals. AMRN Ireland, biopharmaceutical company: Biopharmaceutical company; therapies for serious and neglected rare cardiovascular diseases. BCRX Infectious and inflammatory diseases. NVAX Vaccine company; products to prevent infectious diseases.

AUPH Canada, biopharmaceutical company: ENTA Small molecule drugs for viral infections and liver diseases. Gene therapy company with a focus on rare neurological genetic diseases. Biohaven Pharmaceutical Holding Company Ltd.

CARA Chemical entities designed to alleviate pain and pruritus.